A C3 convertase assay for nephritic factor functional activity

被引:18
|
作者
Jelezarova, E
Schlumberger, M
Sadallah, S
Späth, PJ
Schifferli, JA
Lutz, HU [1 ]
机构
[1] ETH Zentrum, Swiss Fed Inst Technol, Inst Biochem, CH-8092 Zurich, Switzerland
[2] Univ Basel Hosp, Dept Med, CH-4031 Basel, Switzerland
[3] SRC, ZLB Cent Lab, Blood Transfus Serv, Bern, Switzerland
关键词
C3 nephritic factor; C3; convertase; complement; C3b(2)-IgG;
D O I
10.1016/S0022-1759(01)00295-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
C3 nephritic factor (C3NeF) is an autoantibody against the C3 convertase which stabilizes this otherwise inherently labile neoenzyme and induces a continuous activation of the alternative pathway with C3 depletion. NeF is found in patients with membranoproliferative glomerulonephritis and/or partial lipodystrpohy. NeF activity is usually detected in plasma by hemolytic tests. In order to obtain reproducible data for the functional activity of purified C3NeF IgG a solid phase assay was developed. C3 convertase was generated on immobilized C3b by incubation with factors B and D in the presence of Ni2+. Convertase sites were left to decay in the presence of normal IgG or NeF IgG. Residual convertase activity was measured by adding I-125-C3 and capturing nascent I-125-C3b on the plate surface via covalently coupled NH2-Glu-Tyr dipeptide, In the presence of factor H during C3 convertase decay, a dose dependent stabilizing activity was shown for NeF IgG including NeF IgG purified from urine. A second format of the assay was developed in which C3 convertase was assembled on C3b(2)-IgG complexes in the presence of Mg2+. Since these complexes are more efficient as convertase precursors the signal was five-fold higher than with C3b. Convertase decay, on the other hand, was not influenced by the nature of the precursor and in both systems the stabilizing activity of NeF IgG was similar. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 50 条
  • [1] COFACTORS REQUIRED BY C3 NEPHRITIC FACTOR TO GENERATE A C3 CONVERTASE INVITRO
    AMOS, N
    SISSONS, JGP
    GIRARD, JF
    LACHMANN, PJ
    PETERS, DK
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1976, 24 (03): : 474 - 482
  • [2] INHIBITION OF NEPHRITIC FACTOR-DEPENDENT C3 CONVERTASE - ISOLATION OF A NATURAL INHIBITOR OF C3 CONVERSION FROM SERUM OF A PATIENT WITH NEPHRITIC FACTOR AND NEPHRITIS
    LISE, H
    JACQUES, L
    JOURNAL OF IMMUNOLOGY, 1978, 120 (05): : 1776 - 1777
  • [3] A NOVEL ELISA ASSAY FOR THE DETECTION OF C3 NEPHRITIC FACTOR
    SEINO, J
    BAKE, AWLVDW
    VANES, LA
    DAHA, MR
    JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 159 (1-2) : 221 - 227
  • [4] C3 NEPHRITIC FACTOR - STABILIZATION OF ALTERNATIVE PATHWAY CONVERTASE AND POSSIBLE RELATIONSHIP TO PROPERDIN
    DAHA, MR
    FEARON, DT
    AUSTEN, KF
    CLINICAL RESEARCH, 1975, 23 (03): : A410 - A410
  • [5] TRANSFER OF C3 NEPHRITIC FACTOR FROM MOTHER TO FETUS - IS C3 NEPHRITIC FACTOR IGG
    DAVIS, AE
    ARNAOUT, MA
    ALPER, CA
    ROSEN, FS
    NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (03): : 144 - 145
  • [6] Improvement of clinical immunofixation electrophoresis assay for C3 nephritic factor
    Borowiec, Alexander
    Murrell, Matthew
    Reid, Carter
    Knight, Vijaya
    Dennis, Jaclyn
    MOLECULAR IMMUNOLOGY, 2018, 102 : 135 - 136
  • [7] IDENTIFICATION OF C3 NEPHRITIC FACTOR
    WILLIAMS, DG
    JOURNAL OF IMMUNOLOGY, 1978, 120 (05): : 1802 - 1802
  • [8] BINDING OF C3 NEPHRITIC FACTOR (C3NEF) TO FLUID PHASE AMPLIFICATION CONVERTASE OF COMPLEMENT
    DAHA, MR
    AUSTEN, KF
    FEARON, DT
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 1244 - 1244
  • [9] C-3 NEPHRITIC FACTOR STABILIZATION OF THE CLASSIC C-3 CONVERTASE - ROLE FOR C2 IN C-3 NEPHRITIC FACTOR ACTIVITY
    MCLEAN, RH
    NILSON, SH
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1979, 161 (03): : 358 - 363
  • [10] ISOLATION OF ALTERNATIVE PATHWAY C3 CONVERTASE CONTAINING UNCLEAVED B AND FORMED IN PRESENCE OF C3 NEPHRITIC FACTOR (C3NEF)
    DAHA, MR
    FEARON, DT
    AUSTEN, KF
    JOURNAL OF IMMUNOLOGY, 1976, 116 (02): : 568 - 570